These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35278294)

  • 21. Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report.
    Minish T; Herd A
    J Emerg Med; 2002 Apr; 22(3):247-9. PubMed ID: 11932086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe bradycardia due to interaction of timolol eye drops and verapamil.
    Pringle SD; MacEwen CJ
    Br Med J (Clin Res Ed); 1987 Jan; 294(6565):155-6. PubMed ID: 3109547
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism of ophthalmic timolol: new aspects of an old drug.
    Volotinen M; Hakkola J; Pelkonen O; Vapaatalo H; Mäenpää J
    Basic Clin Pharmacol Toxicol; 2011 May; 108(5):297-303. PubMed ID: 21385322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
    Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
    Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.
    Schmier JK; Covert DW; Lau EC
    Clin Drug Investig; 2012 Dec; 32(12):835-42. PubMed ID: 23138648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
    Kobayashi H
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.
    Konstas AG; Maltezos A; Bufidis T; Hudgins AG; Stewart WC
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical timolol therapy and cardiopulmonary function.
    Burggraf GW; Munt PW
    Can J Ophthalmol; 1980 Oct; 15(4):159-60. PubMed ID: 6108154
    [No Abstract]   [Full Text] [Related]  

  • 30. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.
    Nieminen T; Lehtimäki T; Mäenpää J; Ropo A; Uusitalo H; Kähönen M
    Scand J Clin Lab Invest; 2007; 67(2):237-45. PubMed ID: 17366003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
    Zhang WY; Po AL; Dua HS; Azuara-Blanco A
    Br J Ophthalmol; 2001 Aug; 85(8):983-90. PubMed ID: 11466259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic conflict in patients with COVID-19 and glaucoma.
    Millá Griñó E; Muniesa Royo MJ; Pazos López M
    Med Clin (Barc); 2020 Aug; 155(4):182. PubMed ID: 32591182
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation of Ocular Bioactivation Potential and the Role of Cytochrome P450 2D Enzymes in Rat.
    Dumouchel JL; Argikar UA; Spear J; Brown A; Dunne CE; Kramlinger VM; Cirello AL; Gunduz M
    Drug Metab Lett; 2017; 11(2):102-110. PubMed ID: 28891437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
    Watson P; Stjernschantz J
    Ophthalmology; 1996 Jan; 103(1):126-37. PubMed ID: 8628543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
    Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
    Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparison between latanoprost and timolol in treatment of patients with primary open-angle glaucoma and ocular hypertension].
    Peng D; Li S; Li M; Shao H; Sun X; Sheng Y; Yu K; Fu P; Guo W; Meng F; Xu C; Zhu Z
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):285-8. PubMed ID: 11853616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical timolol therapy in pregnancy: is it safe for the fetus?
    Wagenvoort AM; van Vugt JM; Sobotka M; van Geijn HP
    Teratology; 1998 Dec; 58(6):258-62. PubMed ID: 9894675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.